Susan Kalled

Insider Reports History

Location
Boston, MA
Signature
/s/ Susan Kalled
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Kalled:

Company Role Class Num Shares Value Price $ Report Date Ownership
Compass Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 60,000 18 Feb 2022 Direct

Insider Reports Filed by Susan Kalled

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CMPX Compass Therapeutics, Inc. 18 Feb 2022 1 $0 4/A Chief Scientific Officer 23 Feb 2022, 16:30
CMPX Compass Therapeutics, Inc. 17 Feb 2022 1 $0 4 Chief Scientific Officer 18 Feb 2022, 17:55